These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37270168)

  • 1. Chronic Δ9-tetrahydrocannabinol treatment has dose-dependent effects on open field exploratory behavior and [
    Freeman-Striegel L; Hamilton J; Kannappan R; Bell T; Robison L; Thanos PK
    Life Sci; 2023 Aug; 327():121825. PubMed ID: 37270168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study.
    Oviedo A; Glowa J; Herkenham M
    Brain Res; 1993 Jul; 616(1-2):293-302. PubMed ID: 8395305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity.
    Katsidoni V; Kastellakis A; Panagis G
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2273-84. PubMed ID: 23830148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain.
    Sim LJ; Hampson RE; Deadwyler SA; Childers SR
    J Neurosci; 1996 Dec; 16(24):8057-66. PubMed ID: 8987831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex, THC, and hormones: Effects on density and sensitivity of CB
    Farquhar CE; Breivogel CS; Gamage TF; Gay EA; Thomas BF; Craft RM; Wiley JL
    Drug Alcohol Depend; 2019 Jan; 194():20-27. PubMed ID: 30391834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent effects of Delta9-tetrahydrocannabinol on rates of local cerebral glucose utilization in rat.
    Freedland CS; Whitlow CT; Miller MD; Porrino LJ
    Synapse; 2002 Aug; 45(2):134-42. PubMed ID: 12112406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions.
    Romero J; Garcia-Palomero E; Castro JG; Garcia-Gil L; Ramos JA; Fernandez-Ruiz JJ
    Brain Res Mol Brain Res; 1997 Jun; 46(1-2):100-8. PubMed ID: 9191083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta9-tetrahydrocannabinol.
    Romero J; Berrendero F; Manzanares J; Pérez A; Corchero J; Fuentes JA; Fernández-Ruiz JJ; Ramos JA
    Synapse; 1998 Nov; 30(3):298-308. PubMed ID: 9776133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-related changes in CB1 receptor expression and function and the behavioral effects of cannabinoid receptor ligands.
    Ginsburg BC; Hensler JG
    Pharmacol Biochem Behav; 2022 Feb; 213():173339. PubMed ID: 35077729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between the CB1 receptor agonist Delta 9-THC and the CB1 receptor antagonist SR-141716 in rats: open-field revisited.
    Järbe TU; Andrzejewski ME; DiPatrizio NV
    Pharmacol Biochem Behav; 2002 Nov; 73(4):911-9. PubMed ID: 12213538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chronic administration of R-(+)-[2,3-Dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212-2) or delta(9)-tetrahydrocannabinol on cannabinoid receptor adaptation in mice.
    Sim-Selley LJ; Martin BR
    J Pharmacol Exp Ther; 2002 Oct; 303(1):36-44. PubMed ID: 12235230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic nicotine exposure attenuates the effects of Δ
    Manwell LA; Miladinovic T; Raaphorst E; Rana S; Malecki S; Mallet PE
    Brain Behav; 2019 Nov; 9(11):e01375. PubMed ID: 31583843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chronic nicotine exposure on Δ
    Miladinovic T; Manwell LA; Raaphorst E; Malecki SL; Rana SA; Mallet PE
    Pharmacol Biochem Behav; 2020 Jul; 194():172931. PubMed ID: 32353393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex differences in anti-allodynic, anti-hyperalgesic and anti-edema effects of Δ(9)-tetrahydrocannabinol in the rat.
    Craft RM; Kandasamy R; Davis SM
    Pain; 2013 Sep; 154(9):1709-1717. PubMed ID: 23707295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delta9-THC induced hyperphagia and tolerance assessment: interactions between the CB1 receptor agonist delta9-THC and the CB1 receptor antagonist SR-141716 (rimonabant) in rats.
    Järbe TU; DiPatrizio NV
    Behav Pharmacol; 2005 Sep; 16(5-6):373-80. PubMed ID: 16148441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.
    Craft RM; Wakley AA; Tsutsui KT; Laggart JD
    J Pharmacol Exp Ther; 2012 Mar; 340(3):787-800. PubMed ID: 22182934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Δ
    Gatch MB; Forster MJ
    Psychopharmacology (Berl); 2018 Mar; 235(3):673-680. PubMed ID: 29138877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor mechanism and antiemetic activity of structurally-diverse cannabinoids against radiation-induced emesis in the least shrew.
    Darmani NA; Janoyan JJ; Crim J; Ramirez J
    Eur J Pharmacol; 2007 Jun; 563(1-3):187-96. PubMed ID: 17362921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Δ(9)-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids in mice and rats.
    Gatch MB; Forster MJ
    Psychopharmacology (Berl); 2016 May; 233(10):1901-10. PubMed ID: 26875756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral Characterization of the Effects of Cannabis Smoke and Anandamide in Rats.
    Bruijnzeel AW; Qi X; Guzhva LV; Wall S; Deng JV; Gold MS; Febo M; Setlow B
    PLoS One; 2016; 11(4):e0153327. PubMed ID: 27065006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.